Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Emotional awareness therapy shows promise for migraine sufferers

NCT ID NCT05837650

Symptom relief Sponsor: University of Utah Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tested a new behavioral treatment called Emotional Awareness and Expression Therapy (EAET) for people with migraines. Thirty adults with frequent migraines were randomly assigned to either EAET or a control group. The therapy involved 8 weekly online sessions where participants learned to identify and express suppressed emotions. The goal was to see if EAET could reduce the number of migraine days and improve quality of life.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Emotional Awareness and Expression Therapy (EAET)
What this could lead to
If it works, this could offer a new drug-free way to reduce migraine attacks and improve quality of life.
What could go wrong
This is a very small pilot study with only 30 participants, so results may not apply to everyone. The therapy requires significant time and effort, and it may not work for all migraine types.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

30 people

The number who actually took part.

Started

Apr 2023

Finished

Mar 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults of all genders, ages 18-80. * A diagnosis of either episodic or chronic migraine (with or without aura) by a licensed neurologist. * A migraine disability assessment scores higher than 6. * A stable medication regimen for a minimum of 3 months. * Must have had migraines for at least 1 year. * Must have a minimum of 4 migraine days per month. Exclusion Criteria: * Serious psychiatric disorders (e.g., schizophrenia or bipolar disorder) uncontrolled with medications. * Active suicidal ideation. * Risk of violent behavior. * Untreated alcohol or substance use disorder. * Substantial cognitive impairment. * A diagnosis of medication overuse headaches. * Changes in migraine medication in the past 3 months. * Enrollment in another treatment study. * Current involvement in health-related litigation or disability application. * Inability to use a computer and/or smartphone. * limited access to the internet. * Inability to communicate in English. * Failure to complete at least 85% of the daily diaries during the baseline 30-day diary assessment.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Migraine disorders are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

migraine disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Migraine disorders

Contacts and locations

Locations

  • Dan Kaufmann

    Salt Lake City, Utah, 84117, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.